Efflux genes and active efflux activity detection in Malaysian clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA)

Journal of Basic Microbiology

Volumn 48, Issue 4, 2008, Pages 245-251

  Saiful, Azmi Johari ^a   Mastura, Mohtar ^a   Zarizal, Suhaili ^b   Mazurah, Mohamed Isa ^a   Shuhaimi, Mustafa ^c   Ali, Abdul Manaf ^b  

^a FOREST RESEARCH INSTITUTE MALAYSIA   (Malaysia)

^b UNIVERSITI SULTAN ZAINAL ABIDIN   (Malaysia)

^c UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Efflux genes; Efflux mediated resistance; Methicillin resistant Staphylococcus aureus; MRSA; norA and mdeA

Indexed keywords

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

ANTIINFECTIVE AGENT; BACTERIAL DNA; BACTERIAL PROTEIN; CARRIER PROTEIN; ETHIDIUM; MDEA PROTEIN, STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE PROTEIN; NORA PROTEIN, STAPHYLOCOCCUS; RESERPINE;

ARTICLE; CHEMISTRY; DNA SEQUENCE; DRUG EFFECT; GENETICS; ISOLATION AND PURIFICATION; MALAYSIA; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PENICILLIN RESISTANCE; POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DNA, BACTERIAL; ETHIDIUM; MALAYSIA; MEMBRANE TRANSPORT PROTEINS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; POLYMERASE CHAIN REACTION; RESERPINE; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, AMINO ACID; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 54049140027     PISSN: 0233111X     EISSN: 15214028     Source Type: Journal    
DOI: 10.1002/jobm.200700387     Document Type: Article

References (34)

1. Yamada, Y., Hideka, K., Shiota, S., Kuroda, T. and Tsuchiya, T., 2006. Gene cloning and characterization of SdrM, a chromosamally-encoded multidrug efflux pump, from Staphylococcus aureus. Biol. Pharm. Bull., 29, 554-556.
2. Lomovskaya, O. and Watkins, W.J. 2001. Efflux pumps: their role in antibacterial drug discovery. Curr. Med. Chem., 8, 1699-1771.
3. Kuroda, M., Ohta, T., Uchiyama, I. Baba, T. Yuzawa, H. et al., 2001. Whole genome sequencing of methicillin-resistant Staphylococcus aureus. Lancet, 357, 1225-1240.
4. Poole, K., 2000. Efflux-mediated resistance to fluoroquinolones in gram-positive bacteria and the mycobacteria. Antimicrob. Agents Chemother., 44, 2595-2599.
5. Poole, K., 2005. Efflux-mediated antimicrobial resistance. J. Antimicrob. Chemother., 56, 20-51.
6. Huang, J., O'Toole, P.W., Shen, W., Amrihe-Madsen, H., Jiang, X. et al., 2004. Novel chromosomally encoded multidrug efflux transporter MdeA in Staphylococcus aureus. Antimicrob. Agents Chemother., 48, 909-917.
7. Yamada, Y., Shiota, S., Mizushima, T., Kuroda, T. and Tsuchiya, T., 2006. Functional gene cloning and characterization of MdeA, a multidrug efflux pump from Staphylococcus aureus. Biol. Pharm. Bull., 29, 801-804.
8. Noguchi, N., Okihara, T., Namiki, Y., Kumaki, Y. and Yamanaka, Y., 2005. Susceptibility and resistance genes to fluoroquinolones in methicillin-resistant Staphylococcus aureus isolated in 2002. Int. J. Antimicrob. Agents, 25, 374-379.
9. Neyfakh, A.A., Borsch, C.M. and Kaatz, G.W., 1993. Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter. Antimicrob. Agents Chemother., 37, 128-129.
10. Paulsen, I.T., Brown M.H. and Skurray. R.A. 1996. Proton-dependent multidrug efflux systems. Microbiol. Rev., 60, 575-608.
11. Kristiansen, M.M., Leandro, C., Ordway, D., Martins, M., Viveiros, M. et al., 2003. Phenothiazines alter resistance of methicillin-resistant Staphylococcus aureus (MRSA) to oxacillin in vitro. Int. J. Antimicrob. Agents, 22, 250-253.
12. Gibbons, S., Oluwatuyi, M. and Kaatz, G.W., 2003. A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus. J. Antimicrob. Chemother., 51, 13-17.
13. Oluwatuyi, M., G.W. Kaatz and S. Gibbons. 2004. Antibacterial and resistance modifying activity of Rosmarinus officinalis. Phytochemistry, 65, 3249-3254.
14. Saiful, A.J., Mastura, M., Zarizal, S., Mazurah, M.I., Shuhaimi, M. et al., 2006. Detection of methicillin-resistant Staphylococcus aureus u sing mecA/nuc genes and antibiotic susceptibility profile of Malaysian clinical isolates. World J. Microb. Biot., 22, 1289-1294.
15. Takahata, M., Yonezawa, M., Kurose, S., Futakuchi, N., Matsubara, N. et al., 1996. Mutations in the gyrA and grlA genes of quinolone-resistant clinical isolates of methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother., 38, 543-546.
16. Kaatz, G.W., Seo, S.M. and Ruble, C.A., 1993. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus. Antimicrob. Agents Chemother., 37, 1086-1094.
17. Hall, T.A., 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser., 41, 95-98.
18. Schmitz, F.J., Hertel, B., Hofmann, B., Scheuring, S. and Verhoef, J., 1998. Relationship between mutations in the coding and promoter regions of the norA genes in 42 unrelated clinical isolates of Staphylococcus aureus and the MICs of norfloxacin for these strains. J. Antimicrob. Chemother., 42, 561-563.
19. Kaatz, G.W., Thyagarajan, R.V., Seo, S.M., 2005. Effect of promoter region mutations and mgrA overexpression on transcription of norA, which encodes a Staphylococcus aureus multidrug efflux transporter. Antimicrob. Agents Chemother., 49, 161-169.
20. Horii, T., Suzuki, Y., Monji, A., Morita, M., Muramatsu, H. et al., 2003. Detection of mutations in quinolone resistance-determining regions in levofloxacin- and methicillinresistant Staphylococcus aureus: effects of the mutations on fluoroquinolone MICs. Diagn. Microbiol. Infect. Dis., 46, 139-145.
21. Yoshida, H., Bogaki, M., Nakamura, S., Ubukata, K. and Konno, M., 1990. Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J. Bacteriol., 172, 6942-6949.
22. Holden, M.T., Feil, E.J., Lindsay, J.A., Peacock, S.J., Day, N.P. et al., 2004. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc. Natl. Acad. Sci. USA, 101, 9786-9791.
23. Lindsay, J.A., Moore, C.E., Day, N.P., Peacock, S.J., Witney, A.A. et al., 2006. Microarrays reveal that each of the ten dominant lineages of Staphylococcus aureus has a unique combination of surface-associated and regulatory genes. J. Bacteriol., 188, 669-676.
24. Fitzgerald, J.R., Sturdevant, D.E., Mackie, S.M., Gill, S.R. and Musser, J.M., 2001. Evolutionary genomics of Staphylococcus aureus: insights into the origin of methicillinresistant strains and the toxic shock syndrome epidemic. Proc. Natl. Acad. Sci. USA, 98, 8821-8826.
25. Noguchi, N., Tamura, M., Narui, K., Wakasugi, K. and Sasatsu, M., 2002. Frequency and genetic characterization of multidrug-resistant mutants of Staphylococcus aureus after selection with individual antiseptics and fluoroquinolones. Biol. Pharm. Bull., 25, 1129-1132.
26. Zhang, Y.Q., Ren, S.X., Li, H.L., Wang, Y.X., Fu, G. et al., 2003. Genome-based analysis of virulence genes in a non-biofilm-forming Staphylococcus epidermidis strain (ATCC 12228). Mol. Microbiol., 49, 1577-1593.
27. Putman, M. and Veen, H.W.V., Konings, W.N., 2000. Molecular Properties of Bacterial Multidrug Transporters. Microbiol. Mol. Biol. Rev., 64, 672-693.
28. Bambeke, F.V., Glupczynski, Y., Plesiat, P., Pechere, J.C. and Tulkens, P.M., 2003. Antibiotic efflux pumps in prokaryotic e future of antimicrobial therapy. J. Antimicrob. Chemother., 51, 1055-1065.
29. Choi C.S., Yin, C.S., Bakar, A., Sakewi, Z., Naing, N.N. et al., 2006. Nasal carriage of Staphylococcus aureus among healthy adults. J. Microbiol. Immunol. Infect., 39, 458-464.
30. Rohani, M.Y., Raudah, A., Lau, M.G., Zaidatul, A.A., Salbiah, M.N. et al., 2000. Susceptibility pattern of Staphylococcus aureus isolated in Malaysian hospitals. Int. J. Antimicrob. Agents, 13, 209-213.
31. Pereda-Miranda, R., Kaatz, G.W. and Gibbons, S., 2006. Polyacylated oligosaccharides from medicinal Mexican Morning Glory species as antibacterials and inhibitors of multidrug resistance in Staphylococcus aureus. J. Nat. Prod., 69, 406-409.
32. Stermitz, F.R., Scriven, L.N., Tegos, G. and Lewis, K., 2002. Two flavonols from Artemisa annua which potentiate the activity of berberine and norfloxacin against a resistant strain of Staphylococcus aureus. Planta Medica, 68, 1140-1141.
33. Choudhuri, B.S., Bhakta, S., Barik, R., Basu, J. et al., 2002. Overexpression and functional characterization of an ABC (ATP-binding cassette) transporter encoded by the genes drrA and drrB of Mycobacterium tuberculosis. Biochem. J., 367, 279-285.
34. Aeschlimann, J.R., Dresser, L.D., Kaatz, G.W. and Rybak, M.J., 1999. Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effect of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus. Antimicrob. Agents Chemother., 43, 335-340.